Verano Holdings (VRNO) Cash from Investing Activities (2021 - 2026)

Verano Holdings (VRNO) reported Cash from Investing Activities of -$14.9 million for Q1 2026, down 212.45% year-over-year from $13.3 million in Q1 2025, and down 49.56% quarter-over-quarter from -$10.0 million in Q4 2025.

Verano Holdings (VRNO) Cash from Investing Activities (2021 - 2026) Analysis & Trends

Verano Holdings (VRNO) has 6 years of Cash from Investing Activities data on file, last reported at -$14.9 million in Q1 2026.

  • Cash from Investing Activities for Q1 2026 came in at -$14.9 million, down 212.45% year-over-year; the trailing twelve-month figure through Mar 2026 was -$42.7 million (up 66.7% YoY), and the FY2025 annual result was -$32.6 million, up 75.53% from the prior year.
  • Cash from Investing Activities fell to -$14.9 million in Q1 2026 per VRNO's latest filing, from -$10.0 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at -$4.8 million in Q1 2025 and troughed at -$92.6 million in Q3 2024.
  • A 5-year average of -$24.9 million and a median of -$10.4 million in 2025 frame the typical range for Cash from Investing Activities.
  • The sharpest annual moves came in 2023 and 2024: Cash from Investing Activities jumped 92.25% in 2023, then tumbled 830.65% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at -$22.6 million in 2022, then surged by 56.45% to -$9.8 million in 2023, then slipped by 26.17% to -$12.4 million in 2024, then grew by 19.61% to -$10.0 million in 2025, then tumbled by 49.56% to -$14.9 million in 2026.
  • Business Quant data shows VRNO's Cash from Investing Activities at -$14.9 million in Q1 2026, -$10.0 million in Q4 2025, and -$7.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 229.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -87.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 743.70 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -506.20 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -60.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -2.08 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -15.45 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 25.99 Mn
10 Verano Holdings - - 98.98 Mn -14.91 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -14.91 Mn
Mar 31, 2026 -14.91 Mn
Dec 31, 2025 -9.97 Mn
Dec 31, 2025 -9.97 Mn
Sep 30, 2025 -7.45 Mn
Sep 30, 2025 -7.45 Mn
Jun 30, 2025 -10.41 Mn
Jun 30, 2025 -10.41 Mn
Mar 31, 2025 -4.77 Mn
Mar 31, 2025 -4.77 Mn
Dec 31, 2024 -12.40 Mn
Dec 31, 2024 -12.40 Mn
Sep 30, 2024 -92.64 Mn
Sep 30, 2024 -92.64 Mn
Jun 30, 2024 -18.52 Mn
Jun 30, 2024 -18.52 Mn
Mar 31, 2024 -9.70 Mn
Mar 31, 2024 -9.70 Mn
Dec 31, 2023 -9.83 Mn
Dec 31, 2023 -9.83 Mn